bioAffinity Technologies, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 176.90 K | $45.99 K | -32.19% | 1.09% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 118.69 K | $30.86 K | 19.22% | 0.73% |
SHEAFF BROCK INVESTMENT ADVISORS, LLC | 05/07/2025 | 53.73 K | $13.97 K | 16.05% | 0.33% |
CAPTRUST FINANCIAL ADVISORS | 05/15/2025 | 27.89 K | $7.25 K | 0.00% | 0.17% |
WARBERG ASSET MANAGEMENT LLC | 05/09/2025 | 22.50 K | $5.87 K | 100.00% | 0.14% |
HRT FINANCIAL LP | 05/15/2025 | 18.84 K | $4.00 K | 100.00% | 0.12% |
STATE STREET CORP | 05/15/2025 | 17.60 K | $4.58 K | 0.00% | 0.11% |
VAN HULZEN ASSET MANAGEMENT, LLC | 05/14/2025 | 16.01 K | $4.16 K | 100.00% | 0.10% |
IFP ADVISORS, INC | 05/05/2025 | 15.00 K | $3.90 K | 50.00% | 0.09% |
NORTHERN TRUST CORP | 05/13/2025 | 13.66 K | $3.55 K | 0.00% | 0.08% |
XTX TOPCO LTD | 05/08/2025 | 12.61 K | $3.28 K | 18.76% | 0.08% |
CREATIVE PLANNING | 05/15/2025 | 12.10 K | $3.15 K | 0.00% | 0.07% |
BARCLAYS PLC | 05/15/2025 | 3.18 K | $1.00 K | 100.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.14 K | $817 | -50.39% | 0.02% |
MORGAN STANLEY | 05/15/2025 | 300 | $78 | -40.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 88 | $23 | 4.76% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 18 | $5 | -14.29% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
OARSMAN CAPITAL, INC. | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
bioAffinity Technologies, Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of bioAffinity Technologies, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 176,897
GEODE CAPITAL MANAGEMENT, LLC: 118,689
Sheaff Brock Investment Advisors, LLC: 53,734
CAPTRUST FINANCIAL ADVISORS: 27,885
Warberg Asset Management LLC: 22,500
HRT FINANCIAL LP: 18,841
3.15% of bioAffinity Technologies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 512.25 K shares in the last 24 months. This purchase volume represents approximately $125.50 K in transactions.